Champions Oncology Overview
- Year Founded
-
1985
- Status
-
Public
- Employees
-
214
- Stock Symbol
-
CSBR
- Investments
-
1
- Share Price
-
$4.34
- (As of Friday Closing)
Champions Oncology General Information
Description
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
Contact Information
Website
www.championsoncology.comCorporate Office
- One University Plaza
- Suite 307
- Hackensack, NJ 07601
- United States
Corporate Office
- One University Plaza
- Suite 307
- Hackensack, NJ 07601
- United States
Champions Oncology Stock Performance
As of 20-Nov-2026, Champions Oncology’s stock price is $4.34. Its current market cap is $60.4M with 13.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.34 | $4.40 | $4.34 - $8.31 | $60.4M | 13.9M | 9.7K | -$0.08 |
Champions Oncology Financials Summary
As of 31-Jul-2026, Champions Oncology has a trailing 12-month revenue of $60.7M.
|
In Thousands, USD |
TTM 31-Jul-2026 | FY 2026 30-Apr-2026 | FY 2025 30-Apr-2025 | FY 2024 30-Apr-2024 |
|---|---|---|---|---|
| EV | 74,239 | 80,627 | 102,097 | 69,204 |
| Revenue | 60,661 | 59,425 | 56,944 | 50,155 |
| EBITDA | 441 | 448 | 6,266 | (5,441) |
| Net Income | (1,073) | (1,175) | 4,701 | (7,276) |
| Total Assets | 33,290 | 26,989 | 32,344 | 26,132 |
| Total Debt | 10,521 | 4,512 | 6,105 | 7,430 |
Champions Oncology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Champions Oncology Comparisons
Industry
Financing
Details
Champions Oncology Competitors (13)
One of Champions Oncology’s 13 competitors is Eocene (Drug Discovery), a Corporation company based in Ramat Gan, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eocene (Drug Discovery) | Corporation | Ramat Gan, Israel | ||||
| Amryt Pharma | Corporate Backed or Acquired | London, United Kingdom | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Sygnature Discovery | Private Equity-Backed | Nottingham, United Kingdom |
Champions Oncology Patents
Champions Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025174721-A1 | Vps4 inhibitors | Pending | 12-Feb-2024 | ||
| US-20260232824-A1 | Anti-cd180 binding molecules and uses thereof | Pending | 03-Feb-2023 | ||
| WO-2024163920-A2 | Anti-cd180 binding molecules and uses thereof | Inactive | 03-Feb-2023 | ||
| WO-2024163920-A3 | Anti-cd180 binding molecules and uses thereof | Inactive | 03-Feb-2023 | ||
| CA-2995574-A1 | Personalized treatment of diseases and disorders | Inactive | 13-Aug-2015 | C12Q1/6886 |
Champions Oncology Signals
Champions Oncology Acquisitions (1)
Champions Oncology’s most recent deal was a Merger/Acquisition with Biomerk for . The deal was made on 18-May-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biomerk | 18-May-2007 | Merger/Acquisition | Drug Discovery |
Champions Oncology ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Champions Oncology Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Corellia AI | Rockville, MD | 2020 |
Champions Oncology FAQs
-
When was Champions Oncology founded?
Champions Oncology was founded in 1985.
-
Where is Champions Oncology headquartered?
Champions Oncology is headquartered in Hackensack, NJ.
-
What is the size of Champions Oncology?
Champions Oncology has 214 total employees.
-
What industry is Champions Oncology in?
Champions Oncology’s primary industry is Discovery Tools (Healthcare).
-
Is Champions Oncology a private or public company?
Champions Oncology is a Public company.
-
What is Champions Oncology’s stock symbol?
The ticker symbol for Champions Oncology is CSBR.
-
What is the current stock price of Champions Oncology?
As of 20-Nov-2026 the stock price of Champions Oncology is $4.34.
-
What is the current market cap of Champions Oncology?
The current market capitalization of Champions Oncology is $60.4M.
-
What is Champions Oncology’s current revenue?
The trailing twelve month revenue for Champions Oncology is $60.7M.
-
Who are Champions Oncology’s competitors?
Eocene (Drug Discovery), Amryt Pharma, Exscientia, BPS Bioscience, and Sygnature Discovery are some of the 13 competitors of Champions Oncology.
-
What is Champions Oncology’s annual earnings per share (EPS)?
Champions Oncology’s EPS for 12 months was -$0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process